12/17
08:53 am
pbm
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial [Yahoo! Finance]
Low
Report
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial [Yahoo! Finance]
12/17
08:37 am
pbm
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
Low
Report
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
12/17
07:47 am
pbm
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial [Yahoo! Finance]
Medium
Report
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial [Yahoo! Finance]
12/6
01:28 pm
pbm
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations [Canadian Business Journal (Canada)]
Low
Report
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations [Canadian Business Journal (Canada)]
12/6
11:06 am
pbm
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations
Medium
Report
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations
12/3
07:42 am
pbm
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress [Yahoo! Finance]
High
Report
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress [Yahoo! Finance]
12/3
07:30 am
pbm
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
High
Report
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
11/24
08:50 pm
pbm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector [Yahoo! Finance]
High
Report
Weekly Roundup on the Cannabis Sector & Psychedelic Sector [Yahoo! Finance]
11/20
07:39 am
pbm
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing [Yahoo! Finance]
Medium
Report
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing [Yahoo! Finance]
11/20
07:30 am
pbm
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing
Medium
Report
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing
11/19
05:28 pm
pbm
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Canadian Business Journal (Canada)]
Medium
Report
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Canadian Business Journal (Canada)]
11/19
04:11 pm
pbm
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Yahoo! Finance]
Low
Report
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Yahoo! Finance]
11/19
04:05 pm
pbm
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
Low
Report
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
11/12
04:30 pm
pbm
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq
High
Report
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq
10/31
09:33 am
pbm
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]
High
Report
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]
10/31
09:30 am
pbm
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
High
Report
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
10/31
07:30 am
pbm
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
Medium
Report
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
10/25
09:52 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Financial Post (Toronto, Ontari
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Financial Post (Toronto, Ontari
10/25
09:50 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Yahoo! Finance]
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Yahoo! Finance]
10/25
09:42 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
10/24
07:00 am
pbm
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
High
Report
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
10/17
07:00 am
pbm
Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development
High
Report
Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development
10/14
10:48 am
pbm
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical [Yahoo! Finance]
Low
Report
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical [Yahoo! Finance]
10/14
10:46 am
pbm
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical [Financial Post (Toronto, Ontario, Canada)]
10/14
10:43 am
pbm
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical
Low
Report
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical